| Name | Title | Contact Details |
|---|---|---|
Sharon Bridges |
Vice President and Deputy General Counsel | Profile |
Renee Wroth |
Chief Compliance and Privacy Officer | Profile |
Vanessa Smith |
Vice President and Chief General Counsel | Profile |
Michael Knapik |
Vice President, Government and Community Relations | Profile |
Kyle Deskus |
Assistant General Counsel | Profile |
Advocate Health is redefining how, when and where care is delivered to help people live well. We`re providing equitable care for all in our communities and using our combined strength and expertise to deliver better outcomes at a lower cost. Headquartered in Charlotte, North Carolina, we have a combined footprint across six states – Alabama, Georgia, Illinois, North Carolina, South Carolina and Wisconsin – and maintain a strong organizational presence in Chicago and Milwaukee.
Betz Nursing Home is a Auburn, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kips Bay Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.
Mahaska Health Partnership is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Oskaloosa, IA. To find more information about Mahaska Health Partnership, please visit www.mahaskahealth.org